Promethera Biosciences appoints Mutsuki Takano as GM
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the appointment of Mutsuki Takano as Branch General Manager of Promethera Biosciences Japan Branch and Member of the Management Team of Promethera Biosciences SA. As announced in May 2018, Promethera’s branch office in Tokyo marks the starting point for building a strong presence of Promethera in Japan and additional Asian markets. Mutsuki Takano joins Promethera from Mitsui & Co., Ltd, one of the biggest Japanese conglomerate where he was influential in international business activities such as new company launches, the set-up of joint ventures, foreign company operations and restructuring projects in the US, UK, India, China, and other Asian countries. Most recently, his work focused on private equity transactions in the biotechnology sector for Mitsui Global Investment, the venture capital arm of Mitsui & Co. Ltd. Mutsuki has contributed to the successful development of more than 10 portfolio companies as a board observer. He received a Bachelor of Science in Politics and Economics from the Waseda University, Tokyo, Japan and did his EMBA at Sun Yat-Sen University, Guangzhou, China.